ANTISENSE OLIGODEOXYNUCLEOTIDE TO THE CCKB RECEPTOR PRODUCES NALTRINDOLE AND [LEU(5)]ENKEPHALIN ANTISERUM-SENSITIVE ENHANCEMENT OF MORPHINE ANTINOCICEPTION

被引:41
作者
VANDERAH, TW [1 ]
LAI, J [1 ]
YAMAMURA, HI [1 ]
PORRECA, F [1 ]
机构
[1] UNIV ARIZONA,HLTH SCI CTR,DEPT PHARMACOL,TUCSON,AZ 85724
关键词
CCKB RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDES; ENKEPHALINS; ANTINOCICEPTION; MOUSE;
D O I
10.1097/00001756-199412000-00049
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
CHOLECYSTOKININ (CCK) has been shown to attenuate, while CCK antagonists enhance, the antinociceptive activity of morphine, suggesting that this peptide may act as an endogenous modulator of the opioid system. Here, we have investigated the effects of administration of a synthetic oligodeoxynucleotide (oligo) complementary to the 5' coding region of the cloned mouse CCKB receptor (antisense), or a mismatch oligo, on the antinociceptive effects of morphine. Intracerebroventricular (i.c.v.) treatment of mice with CCKB antisense, but not mismatch, oligo for 3 days resulted in an enhancement of the antinociceptive potency of i.c.v. morphine, as indicated by an approximately 6-fold leftward shift of the dose-effect curve. The antinociceptive effects of morphine in control and CCKB antisense-treated animals were investigated in the presence or absence of naltrindole, an opioid delta receptor antagonist, as well as in the presence or absence of antisera directed against either [Leu(5)]- or [Met(5)]enkephalin. The enhanced potency of morphine in mice pretreated with CCKB antisense oligo was blocked by a delta-selective dose of naltrindole and antisera to [Leu(5)]enkephalin, but not [Met(5)]enkephalin; naltrindole, or antisera towards [Leu(5)]enkephalin or [Met(5)]enkephalin did not produce antinociceptive effects when given alone and did not alter the antinociceptive actions of morphine in control mice. These data suggest that CCK may act via CCKB receptors to tonically inhibit the release of [Leu(5)]enkephalin, or a [Leu(5)]enkephalin-like peptide. The enhancement of morphine antinociception seen in the presence of blockade of the CCKB receptor may be the result of the well-known enhancement of morphine antinociception by opioid delta agonists.
引用
收藏
页码:2601 / 2605
页数:5
相关论文
共 25 条
[21]   RELEASE OF IMMUNOREACTIVE [MET5]ENKEPHALIN AND CHOLECYSTOKININ FROM THE SPINAL-CORD BY BETA-ENDORPHIN ADMINISTERED INTRAVENTRICULARLY IN THE PENTOBARBITAL-ANESTHETIZED RAT [J].
TSENG, LF ;
HUANG, FY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) :309-312
[22]  
VANDERAH TW, 1993, J PHARMACOL EXP THER, V267, P449
[23]  
VANDERAH TW, 1994, UNPUB
[24]   CHOLECYSTOKININ ANTAGONISTS SELECTIVELY POTENTIATE ANALGESIA INDUCED BY ENDOGENOUS OPIATES [J].
WATKINS, LR ;
KINSCHECK, IB ;
KAUFMAN, EFS ;
MILLER, J ;
FRENK, H ;
MAYER, DJ .
BRAIN RESEARCH, 1985, 327 (1-2) :181-190
[25]  
WEISENFELDHALLI.Z, 1990, P NATL ACAD SCI USA, V87, P7105